BAT8007 targets Nectin-4 on the cell surface, is internalized, and releases exatecan, which inhibits topoisomerase I to cause replication-associated DNA damage and cell death. Cells are not killed because they express topoisomerase I per se; killing requires Nectin-4–mediated delivery.